Sea Mild Biotechnology Co., Ltd. (TPEX:7516)

Sea Mild Biotechnology Revenue

Sea Mild Biotechnology had revenue of 165.60M TWD in the half year ending June 30, 2025, with 34.10% growth. This brings the company's revenue in the last twelve months to 348.45M, up 29.29% year-over-year. In the year 2024, Sea Mild Biotechnology had annual revenue of 318.82M with 24.05% growth.

• Revenue (ttm): 348.45M
• Revenue Growth: +29.29%
• P/S Ratio: 0.59
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 204.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	318.82M	61.81M	24.05%
Dec 31, 2023	257.02M	54.37M	26.83%
Dec 31, 2022	202.65M	38.83M	23.71%
Dec 31, 2021	163.82M	-44.06M	-21.20%
Dec 31, 2020	207.88M	-6.26M	-2.92%